Oppenheimer Questions Valuation of Boston Scientific’s $14.5 Billion Penumbra Deal
Boston Scientific Corporation (NYSE:BSX) is one of the best mid-cap growth stocks to buy right now. On January 16, Oppenheimer…
Tag: Penumbra
Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots
Penumbra’s stock was up about 12% after the deal was announced Thursday morning. www.marketwatch.com #Boston #Scientific #buying #Penumbra #billion #business…